Press Release
12 Oct, 2020
46
Beijing, Oct. 12, 2020——InnoCare Pharma (HKEX: 09969), a clinical stage biopharmaceutical company, announced today that the Company has appointed Dr. Manish Tandon as Vice President of Business Development, reporting to the Co-founder, Chairman and CEO, Dr. Jasmine Cui. Dr. Tandon will be responsible for the Company’s business development strategy and execution, external collaborations, licensing and M&A.
2293
16 Sep, 2020
55
Beijing, Sept. 16, 2020——InnoCare Pharmaceuticals, a clinical stage biopharmaceutical company committed to discovering, developing, and commercializing innovative medicines for the treatment of cancer and autoimmune diseases, announced today that the company will present at the upcoming Morgan Stanley 2020 Virtual Asia Pacific Conference and ZGC Forum.
2287
02 Jul, 2020
77
InnoCare Pharmaceuticals (HKEX: 09969), after successfully dosing the first patient in a Phase 2 trial of ICP-192 for urothelial cancer, today announced the first patient dosed in a Phase 2 clinical trial of ICP-192 in patients with cholangiocarcinoma.
2245
28 Jun, 2020
44
InnoCare Pharmaceuticals (HKEX: 09969), a leader in the fields of cancer and autoimmune diseases, today announced the first patient dosed in a Phase 2 clinical trial of ICP-192 in patients with urothelial cancer.
2243
01 Jan, 0001
52
On June 28, 2020, InnoCare (Stock Code:09969-HK), a leading innovator for global biopharmaceutical drugs, is proud to announce the appointment of Mr. Xiaodong Jin as Chief Commercial Officer (CCO).
2241